Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2007 Sep 2:215–234. doi: 10.1016/B978-012369454-6/50036-4

Lactate Dehydrogenase-Elevating Virus

Jean-Paul Coutelier, Margo A Brinton
Editors: James G Fox1, Muriel T Davisson2, Fred W Quimby3, Stephen W Barthold4, Christian E Newcomer5, Abigail L Smith6
PMCID: PMC7155438

Publisher Summary

Lactate dehydrogenase-elevating virus (LDV) is a mouse arterivirus, unusual in its extreme host specificity and its persistence in the circulation of the infected host that naturally infects wild mice. Although, probably not as frequent in laboratory mouse colonies as it used to be, LDV infection may affect experimental results, primarily through its effects on the host immune responses. On the other hand, because of its unique properties, LDV infections serve as a good animal model for viral persistence, virally induced immunomodulation, and pathogenic infection of neurons in the central nervous system. However, the inability of LDV to infect in transformed cell lines and to cause a detectable cytopathic effect in cell cultures in which it replicates, such as mouse peritoneal exudate cells, represents technical obstacles to the further analysis of this virus. Identification of the cell receptor utilized by LDV would constitute a major advance, since this might lead to the creation of a cell line permissive to LDV infection. Whereas LDV is a natural and sometimes pathogenic infectious agent of the mouse, it does not currently represent a major threat to animal facilities. The virus is not very contagious and there are a number of easy methods available to detect infected mice. Moreover, further study of the interaction between relatively silent viruses, such as LDV, and their host species should lead to new insights into the mechanisms by which viruses can establish and maintain relatively harmless, persistent infections in their hosts.

References

  1. Anderson G.W., Even C., Rowland R.R., Palmer G.A., Harty J.T., Plagemann P.G.W. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J. Neurovirol. 1995;1:244–252. doi: 10.3109/13550289509114020. [DOI] [PubMed] [Google Scholar]
  2. Anderson G.W., Palmer G.A., Rowland R.R., Even C., Plagemann P.G.W. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in in utero-infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase-elevating virus. J Virol. 1995;69:308–319. doi: 10.1128/jvi.69.1.308-319.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson G.W., Palmer G.A., Rowland R.R., Even C., Plagemann P.G.W. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons. J. Gen. Virol. 1995;76:581–592. doi: 10.1099/0022-1317-76-3-581. [DOI] [PubMed] [Google Scholar]
  4. Anderson G.W., Rowland R.R.R., Palmer G.A., Even C., Plagemann P.G.W. Lactate dehydrogenase-elevating virus replica-tion persists in liver spleen lymph node and testis tissues and results in accumulation of viral RNA in germinal centers concomitant with polyclonal activation of B cells. J Virol. 1995;69:5177–5185. doi: 10.1128/jvi.69.8.5177-5185.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anderson H.C.V., Riley V., Fitzmaurice M.A., Loveless J.D., Wade P., Moore A.E. Quantitative study of the lactate dehydrogenase-elevating virus in mouse embryo cultures. J. Natl. Cancer Inst. 1966;36:89–95. [PubMed] [Google Scholar]
  6. Anderson H.C.V., Riley V., Wade P., Moore A.E. Quantitative evidence for propagation of the lactate dehydrogenase (LDH) elevating virus in mouse embryo cell cultures. Proc. Am. Assoc. Cancer Res. 1965;6:2. [Google Scholar]
  7. Bailey J.M., Clough J., Stearman M. Clearance of plasma enzymes in normal and LDH agent infected mice. Proc. Soc. Exp. Biol Med. 1964;117:350–354. doi: 10.3181/00379727-117-29578. [DOI] [PubMed] [Google Scholar]
  8. Bailey J.M., Monroe M. Studies on replication of LDH virus. Fed. Proc Fed. Am. Soc. Exp. Biol. 1972;31:836. [Google Scholar]
  9. Bailey J.M., Stearman M., Clough J. LDH levels in blood and tissues of mice infected with an LDH agent. Proc. Soc. Exp. Biol Med. 1963;114:148–153. doi: 10.3181/00379727-114-28610. [DOI] [PubMed] [Google Scholar]
  10. Baron S., Buckler C.E., Friedman R.M., McCloskey R.V. Role of interferon during viraemia in mice. Bacteriol. Proc. 1964;116. [Google Scholar]
  11. Bentley D.M., Morris R.E. T cell subsets required for protection against age-dependent polioencephalomyelitis of C58 mice. J. Immunol. 1982;128:530–534. [PubMed] [Google Scholar]
  12. Bentley D.M., Watson S.R., Morris R.E. Age-related loss of Lyt-1 2 cells in C58 mice results in susceptibility to lactic dehydrogenase virus-induced polioencephalomyelitis. Infect. Immun. 1983;41:1389–1390. doi: 10.1128/iai.41.3.1389-1390.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Brand K.G., Buoen L.C., Johnson K.H., Brand I. Etiological factors stages and the role of the foreign body in foreign body tumorigenesis: a review. Cancer Res. 1975;35:279–286. [PubMed] [Google Scholar]
  14. Brinton M.A., Gavin E.I., Fernandez A.V. Genotypic variation among six isolates of lactate dehydrogenase-elevating virus. J. Gen. Virol. 1986;67:2673–2684. doi: 10.1099/0022-1317-67-12-2673. [DOI] [PubMed] [Google Scholar]
  15. Brinton M.A., Gavin E.I., Weibel J. Detection of viral-specific nucleic acid and intracellular virions in ventral horn neurons of lactate dehydrogenase-elevating virus infected C58 mice. Microb. Pathog. 1986;1:595–602. doi: 10.1016/0882-4010(86)90044-6. [DOI] [PubMed] [Google Scholar]
  16. Brinton M.A., Plagemann P.G.W. Unique response of SJL/J mice to infection with lactate dehydrogenase-elevating virus (LDV) . Annu. Meet. Am. Soc. Microbiol. 1977;Abstr:327. [Google Scholar]
  17. Brinton M.A., Plagemann P.G.W. Actinomycin D cytotoxicity for mouse peritoneal macrophages and effect on lactate dehydrogenase-elevating virus replica-tion. Intervirology. 1980;12:349–356. doi: 10.1159/000149096. [DOI] [PubMed] [Google Scholar]
  18. Brinton-Darnell M., Brand I. Delayed foreign-body tumorigenesis in mice infected with lactate dehydrogenase-elevating virus: brief communi-cation. J. Natl. Cancer Inst. 1977;59:1027–1029. doi: 10.1093/jnci/59.3.1027. [DOI] [PubMed] [Google Scholar]
  19. Brinton-Darnell M., Collins J.K., Plagemann P.G.W. Lactate dehydrogenase-elevating virus replication maturation and viral RNA synthesis in primary mouse macrophage cultures. Virology. 1975;65:187–195. doi: 10.1016/0042-6822(75)90019-7. [DOI] [PubMed] [Google Scholar]
  20. Brinton-Darnell M., Plagemann P.G.W. Structure and chemical-physical characteristics of lactate dehydrogenase-elevating virus and its RNA. J. Virol. 1975;16:420–433. doi: 10.1128/jvi.16.2.420-433.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Broen J.B., Bradley D.S., Powell K.M., Cafruny W.A. Regulation of maternal-fetal virus transmission in immunologically reconsti-tuted SCID mice infected with lactate dehydrogenase-elevating virus. Viral Immunol. 1992;5:133–140. doi: 10.1089/vim.1992.5.133. [DOI] [PubMed] [Google Scholar]
  22. Buxton I.K., Chan S.P.K., Plagemann P.G.W. The IA antigen is not the major receptor for lactate dehydrogenase-elevating virus on macrophages from CBA and BALB/c mice. Virus Res. 1988;9:205–219. doi: 10.1016/0168-1702(88)90031-7. [DOI] [PubMed] [Google Scholar]
  23. Cafruny W.A., Bradley S.E. Trojan horse macrophages: studies with the murine lactate dehydrogenase-elevating virus and implications for sexually transmitted virus infection. J. Gen. Virol. 1996;77:3005–3012. doi: 10.1099/0022-1317-77-12-3005. [DOI] [PubMed] [Google Scholar]
  24. Cafruny W.A., Bradley S.E., Broen J.J., Wong G.H. Cytokine regulation of lactate dehydrogenase-elevating virus: inhibition of viral repli-cation by interferon-gamma. Antiviral Res. 1994;23:191–201. doi: 10.1016/0166-3542(94)90017-5. [DOI] [PubMed] [Google Scholar]
  25. Cafruny W.A., Bradley S.E., Rowland R.R. Regulation of immune complexes during infection of mice with lactate dehydrogenase-ele-vating virus: studies with interferon-gamma gene knockout and tolerant mice. Viral Immunol. 1999;12:163–173. doi: 10.1089/vim.1999.12.163. [DOI] [PubMed] [Google Scholar]
  26. Cafruny W.A., Brunick A., Nelson D.M., Nelson R.F. Effectiveness of ultrasonic cleaning of dental instruments. Am. J. Dent. 1995;8:152–156. [PubMed] [Google Scholar]
  27. Cafruny W.A., Chan S.P., Harty J.T. Antibody response of mice to lactate dehydrogenase-elevating virus during infection and immunization with inactivated virus. Virus Res. 1986;5:357–375. doi: 10.1016/0168-1702(86)90029-8. [DOI] [PubMed] [Google Scholar]
  28. Cafruny W.A., Haven T.R., Lawson S.R., Wong G.H., Rowland R.R.R. Inhibition of virus-induced age-dependent poliomyelitis by interferon-gamma. Antiviral Res. 1997;36:1–9. doi: 10.1016/s0166-3542(97)00031-4. [DOI] [PubMed] [Google Scholar]
  29. Cafruny W.A., Heruth D.P., Jaqua M.J., Plagemann P.G.W. Immunoglobulins that bind to uncoated ELISA plate surfaces: appearance in mice during infection with lactate dehydrogenase-elevating virus and in human anti-nuclear antibody-positive sera. J. Med. Virol. 1986;19:175–186. doi: 10.1002/jmv.1890190211. [DOI] [PubMed] [Google Scholar]
  30. Cafruny W.A., Hovinen D.E. Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies. J. Gen. Virol. 1988;69:723–729. doi: 10.1099/0022-1317-69-3-723. [DOI] [PubMed] [Google Scholar]
  31. Cafruny W.A., Hovinen D.E. The relationship between route of infection and minimum infectious dose: studies with lactate dehydrogenase-elevating virus. J Virol. Methods. 1988;20:265–268. doi: 10.1016/0166-0934(88)90129-2. [DOI] [PubMed] [Google Scholar]
  32. Cafruny W.A., Jones Q.A., Haven T.R., Zitterkopf N.L., Plagemann P.G.W., Rowland R.R. Glucocorticoid regulation of lactate dehydrogenase-elevating virus replication in macrophages. Virus Res. 2003;92:83–87. doi: 10.1016/s0168-1702(02)00321-0. [DOI] [PubMed] [Google Scholar]
  33. Cafruny W.A., Plagemann P.G.W. Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice. Infect. Immun. 1982;37:1001–1006. doi: 10.1128/iai.37.3.1001-1006.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Cafruny W.A., Plagemann P.G.W. Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus. Infect. Immun. 1982;37:1007–1012. doi: 10.1128/iai.37.3.1007-1012.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Cafruny W.A., Strancke C.R., Kowalchyk K., Plagemann P.G.W. Replication of lactate dehydrogenase-elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a func-tion of development of paralytic disease. J. Gen. Virol. 1986;67:27–37. doi: 10.1099/0022-1317-67-1-27. [DOI] [PubMed] [Google Scholar]
  36. Cavanagh D. Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch. Virol. 1997;142:629–633. [PubMed] [Google Scholar]
  37. Chan S.P.K., Onyekaba C.O., Harty J.T., Plagemann P.G.W. Persistent infection of mice by lactate dehydrogenase-elevating virus: transient virus replication in macrophages of the spleen. Virus Res. 1989;14:317–326. doi: 10.1016/0168-1702(89)90024-5. [DOI] [PubMed] [Google Scholar]
  38. Chen Z., Faaberg K.S., Plagemann P.G.W. Detection of negative-stranded subgenomic RNAs but not of free leader in LDV-infected macrophages. Virus Res. 1994;34:167–177. doi: 10.1016/0168-1702(94)90098-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Chen Z., Kuo L., Rowland R.R., Even C., Faaberg K.S., Plagemann P.G.W. Sequences of 3′ end of genome and of 5′ end of open reading frame 1a of lactate dehydrogenase-elevating virus and common junction motifs between 5′ leader and bodies of seven subgenomic mRNAs. J. Gen. Virol. 1993;74:643–659. doi: 10.1099/0022-1317-74-4-643. [DOI] [PubMed] [Google Scholar]
  40. Chen Z., Li K., Plagemann P.G.W. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein. Virology. 2000;266:88–98. doi: 10.1006/viro.1999.0050. [DOI] [PubMed] [Google Scholar]
  41. Chen Z., Li K., Rowland R.R., Anderson G.W., Plagemann P.G.W. Lactate dehydrogenase-elevating virus variants: cosegregation of neuropathogenicity and impaired capability for high viremic persistent infection. J. Neurovirol. 1998;4:560–568. doi: 10.3109/13550289809113501. [DOI] [PubMed] [Google Scholar]
  42. Chen Z., Li K., Rowland R.R., Plagemann P.G.W. Neuropathogenicity and susceptibility to immune response are interdependent properties of lactate dehydrogenase-elevating virus (LDV) and correlate with the number of N-linked polylactosaminoglycan chains on the ectodomain of the primary envelope glycoprotein. Adv. Exp. Med. Biol. 1998;440:583–592. doi: 10.1007/978-1-4615-5331-1_76. [DOI] [PubMed] [Google Scholar]
  43. Rowland R.R., Plagemann P.G.W. Selective antibody neutralization prevents neuropathogenic lactate dehydrogenase-elevating virus from causing paralytic disease in immunocompetent mice. J. Neurovirol. 1999;5:200–208. doi: 10.3109/13550289909022003. [DOI] [PubMed] [Google Scholar]
  44. Chen Z., Plagemann P.G.W. Detection of lactate dehydrogenase-elevating virus in transplantable mouse tumors by biological assay and RT-PCR assays and its removal from the tumor cell. J. Virol. Methods. 1997;65:227–236. doi: 10.1016/s0166-0934(97)02188-5. [DOI] [PubMed] [Google Scholar]
  45. Chen Z., Plagemann P.G.W. Detection of related positive-strand RNA virus genomes by reverse transcription/polymerase chain reaction using degenerate primers for common replicase sequences. Virus Res. 1995;39:365–375. doi: 10.1016/0168-1702(95)00093-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Chen Z., Rowland R.R., Anderson G.W., Palmer G.A., Plagemann P.G.W. Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection. J. Virol. 1997;71:2913–2920. doi: 10.1128/jvi.71.4.2913-2920.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Contag C.H., Chan S.P.K., Wietgrefe S.W., Plagemann P.G.W. Correlation between presence of lactate dehydrogenase-elevating virus RNA and antigens in motor neurons and paralysis in infected C58 mice. Virus Res. 1986;6:195–209. doi: 10.1016/0168-1702(86)90069-9. [DOI] [PubMed] [Google Scholar]
  48. Contag C.H., Plagemann P.G.W. Age-dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal repli-cation of lactate dehydrogenase-elevating virus in motor neurons. J. Virol. 1989;63:4362–4369. doi: 10.1128/jvi.63.10.4362-4369.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Contag C.H., Plagemann P.G.W. Susceptibility of C58 mice to paralytic disease induced by lactate dehydrogenase-elevating virus correlates with increased expression of endogenous retrovirus in motor neurons. Microb. Pathog. 1988;5:287–296. doi: 10.1016/0882-4010(88)90101-5. [DOI] [PubMed] [Google Scholar]
  50. Contag C.H., Retzel E.F., Plagemann P.G.W. Genomic differ-ences between strains of lactate dehydrogenase-elevating virus. Intervirology. 1986;26:228–233. doi: 10.1159/000149705. [DOI] [PubMed] [Google Scholar]
  51. Conzelmann K.K., Visser N., Van Woensel P., Thiel H.-J. Molecular characterization of porcine reproductive and respiratory syndrome virus a member of the arterivirus group. Virology. 1993;193:329–339. doi: 10.1006/viro.1993.1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Coutelier J.P., Coulie P.G., Wauters P., Heremans H., van der Logt J.T. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J. Virol. 1990;64:5383–5388. doi: 10.1128/jvi.64.11.5383-5388.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Coutelier J.P., Van Broeck J., Wolf S.F. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 1995;69:1955–1958. doi: 10.1128/jvi.69.3.1955-1958.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Coutelier J.P., van der Logt J.T., Heessen F.W. Rheumatoid factor production and polyclonal non-antiviral antibody responses elicited by infection with common mouse viruses. J. Autoimmunity. 1990;3:681–686. doi: 10.1016/s0896-8411(05)80035-6. [DOI] [PubMed] [Google Scholar]
  55. Coutelier J.P., van der Logt J.T.M., Heessen F.W.A., Vink A., Van Snick J. Virally induced modulation of murine IgG antibody subclasses. J Exp. Med. 1988;168:2373–2378. doi: 10.1084/jem.168.6.2373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Coutelier J.P., van der Logt J.T.M., Heessen F.W.A., Warnier G., Van Snick J. IgG2a restriction of murine antibodies elicited by viral infec-tions. J Exp. Med. 1987;165:64–69. doi: 10.1084/jem.165.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Coutelier J.P., Van Roost E., Lambotte P., Van Snick J. The murine antibody response to lactate dehydrogenase-elevating virus. J. Gen. Virol. 1986;67:1099–1108. doi: 10.1099/0022-1317-67-6-1099. [DOI] [PubMed] [Google Scholar]
  58. Coutelier J.P., Van Snick J. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur. J. Immunol. 1985;15:250–255. doi: 10.1002/eji.1830150308. [DOI] [PubMed] [Google Scholar]
  59. Coutelier J.P., Van Snick J. Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies. J. Gen. Virol. 1988;69:2097–2100. doi: 10.1099/0022-1317-69-8-2097. [DOI] [PubMed] [Google Scholar]
  60. Crispens C.G. Genetic control of the response of SJL-J mice to LDH virus infection. Arch. Gesamte Virusforsch. 1972;38:225–227. doi: 10.1007/BF01249673. [DOI] [PubMed] [Google Scholar]
  61. Crispens C.G. Studies on the response of SJL-J mice to infection with the lactate dehydrogenase virus. Arch. Gesamte Virusforsch. 1971;35:177–182. doi: 10.1007/BF01249708. [DOI] [PubMed] [Google Scholar]
  62. Crispens C.G., Jr. Effect of statolon on lactate dehydrogenase virus infection in mice. Arch. Gesamte Virusforsch. 1970;31:191–195. doi: 10.1007/BF01253751. [DOI] [PubMed] [Google Scholar]
  63. Crispens C.G., Jr. The lactic dehydrogenase agent: its possible implications for the virologist and the oncologist. Bull. Univ. Md. Sch. Med. 1964;49:vii. [Google Scholar]
  64. Crispens C.G., Jr. On the epizootiology of the lactic dehydrogenase agent. J. Natl. Cancer Inst. 1964;32:497–505. [PubMed] [Google Scholar]
  65. Crispens C.G., Jr. On the properties of the lactic dehydrogenase agent. J. Natl. Cancer Inst. 1965;35:975–979. [PubMed] [Google Scholar]
  66. Crispens C.G., Jr. Properties of lactic dehydrogenase-elevating agents. Anat. Rec. 1965;151:448–449. doi: 10.1007/BF02297020. [DOI] [PubMed] [Google Scholar]
  67. Crispens C.G., Jr. Serum lactic dehydrogenase levels in mice during the devel-opment of autochthonous and chemically induced tumors. J. Natl. Cancer Inst. 1963;30:361–366. [PubMed] [Google Scholar]
  68. Darnell M.B., Plagemann P.G.W. Physical properties of lactic dehydrogenase-elevating virus and its ribonucleic acid. J. Virol. 1972;10:1082–1085. doi: 10.1128/jvi.10.5.1082-1085.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Dempsey W.L., Smith A.L., Morahan P.S. Effect of inapparent murine hepatitis virus infections on macrophages and host resistance. J. Leukoc. Biol. 1986;39:559–565. doi: 10.1002/jlb.39.5.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. de Vries A.A., Chirnside E.D., Horzinek M.C., Rottier P.J. Structural proteins of equine arteritis virus. J. Virol. 1992;66:6294–6303. doi: 10.1128/jvi.66.11.6294-6303.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. duBuy H.G., Johnson M.L. Some properties of the lactic dehy-drogenase agent of mice. J Exp. Med. 1965;122:587–600. doi: 10.1084/jem.122.3.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. duBuy H.G., Johnson M.L. Studies on the in vivo and in vitro multiplication of the LDH virus of mice. J Exp. Med. 1966;123:985–998. doi: 10.1084/jem.123.6.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. duBuy H., Baron S., Uhlendorf C., Johnson M.L. Role of inter-feron in murine lactic dehydrogenase virus infection in vivo and. in vitro. Infect. Immun. 1973;8:977–984. doi: 10.1128/iai.8.6.977-984.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Duffey P.S., Martinez D., Abrams G.D., Murphy W.H. Pathogenetic mechanisms in immune polioencephalomyelitis: induction of disease in immunosuppressed mice. J. Immunol. 1976;116:475–481. [PubMed] [Google Scholar]
  75. Evans R. Further studies on the replication of the lactate dehydrogenase-elevating virus (LDH virus) in mouse peritoneal macrophage cultures. Proc. Soc. Exp. Biol Med. 1970;133:831–836. doi: 10.3181/00379727-133-34574. [DOI] [PubMed] [Google Scholar]
  76. Evans R. Replication of Riley's plasma enzyme-elevating virus. in vitro. J. Gen. Microbiol. 1964;37:vii. [Google Scholar]
  77. Evans R. Replication of Riley's plasma enzyme-elevating virus in tissue culture: the importance of the cellular composition. J. Gen. Virol. 1967;1:363–374. [PubMed] [Google Scholar]
  78. Evans R., Riley V. Circulating interferon in mice infected with the lactate dehydrogenase-elevating virus. J. Gen. Virol. 1968;3:449. doi: 10.1099/0022-1317-3-3-449. [DOI] [PubMed] [Google Scholar]
  79. Evans R., Salaman M.H. Studies on the mechanism of action of Riley virus: III. Replication of Riley's plasma enzyme-elevating virus. in vitro. J Exp. Med. 1965;122:993–1002. doi: 10.1084/jem.122.5.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Even C., Plagemann P.G.W. Pseudotype virions formed between mouse hepatitis virus and lactate dehydrogenase-elevating virus (LDV) medi-ate LDV replication in cells resistant to infection by LDV virions. J. Virol. 1995;69:4237–4244. doi: 10.1128/jvi.69.7.4237-4244.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Even C., Rowland R.R., Plagemann P.G.W. Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus but disappear during the chronic phase of infection. J. Virol. 1995;69:5666–5676. doi: 10.1128/jvi.69.9.5666-5676.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Faaberg K.S., Even C., Palmer G.A., Plagemann P.G.W. Disulfide bonds between two envelope proteins of lactate dehydrogenase-elevating virus are essential for viral infectivity. J. Virol. 1995;69:613–617. doi: 10.1128/jvi.69.1.613-617.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Faaberg K.S., Palmer G.A., Even C., Anderson G.W., Plagemann P.G.W. Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase-elevating virus that differ in neuropathogenicity. Virus Res. 1995;39:331–340. doi: 10.1016/0168-1702(95)00088-7. [DOI] [PubMed] [Google Scholar]
  84. Faaberg K.S., Plagemann P.G.W. The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography. Virology. 1995;212:512–525. doi: 10.1006/viro.1995.1509. [DOI] [PubMed] [Google Scholar]
  85. Faaberg K.S., Plagemann P.G.W. Membrane association of the C-terminal half of the open reading frame la protein of lactate dehydrogenase-elevating virus. Arch. Virol. 1996;141:1337–1348. doi: 10.1007/BF01718835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Faaberg K.S., Plagemann P.G.W. ORF 3 of lactate dehydrogenase-elevating virus encodes a soluble nonstructural highly glycosylated and antigenic protein. Virology. 1997;227:245–251. doi: 10.1006/viro.1996.8310. [DOI] [PubMed] [Google Scholar]
  87. Fenner F. Classification and nomenclature of viruses. Intervirology. 1977;7:44–47. doi: 10.1159/000149938. [DOI] [PubMed] [Google Scholar]
  88. Field E.J., Adams D.H. Riley virus in wild mice. Lancet. 1968;1:868. doi: 10.1016/s0140-6736(68)90340-1. [DOI] [PubMed] [Google Scholar]
  89. Georgii A., Kirschenhofer I. Über die Isolierung von Lactatdehydrogenase-erhöhendem Virus aus wilden M‰usen. Z. Naturforsch. Teil B. 1965;20:1310. [PubMed] [Google Scholar]
  90. Godeny E.K., Chen L., Kumar S.N., Methven S.L., Koonin E.V., Brinton M.A. Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase-elevating virus (LDV) . Virology. 1993;194:585–596. doi: 10.1006/viro.1993.1298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Godeny E.K., Speicher D.W., Brinton M.A. Map location of lac-tate dehydrogenase-elevating virus (LDV) capsid protein (Vp1) gene. Virology. 1990;177:768–771. doi: 10.1016/0042-6822(90)90546-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Godeny E.K., Werner M.R., Brinton M.A. The 3′ terminus of lactate dehydrogenase-elevating virus genome RNA does not contain togavirus or flavivirus conserved sequences. Virology. 1989;172:647–650. doi: 10.1016/0042-6822(89)90208-0. [DOI] [PubMed] [Google Scholar]
  93. Godeny E.K., Zeng L., Smith S.L., Brinton M.A. Molecular characterization of the 3′ terminus of the simian hemorrhagic fever virus genome. J. Virol. 1995;69:2679–2683. doi: 10.1128/jvi.69.4.2679-2683.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Gomez K.A., Coutelier J.-P., Mathieu P.A., Lustig L., Retegui L.A. Autoantibodies to cryptic epitopes elicited by infection with lactate dehydrogenase-elevating virus. Scand. J. Immunol. 2000;51:447–453. doi: 10.1046/j.1365-3083.2000.00704.x. [DOI] [PubMed] [Google Scholar]
  95. Gomez K.A., Coutelier J.P., Retegui L.A. Changes in the speci-ficity of antibodies in mice infected with lactate dehydrogenase-elevating virus. Scand. J. Immunol. 1997;46:168–174. doi: 10.1046/j.1365-3083.1997.d01-107.x. [DOI] [PubMed] [Google Scholar]
  96. Gomez K.A., Longhi S.A., Marino V.J. Effects of various adjuvants and a viral infection on the antibody specificity toward native or cryptic epitopes of a protein antigen. Scand. J. Immunol. 2003;57:144–150. doi: 10.1046/j.1365-3083.2003.01208.x. [DOI] [PubMed] [Google Scholar]
  97. Goto K., Takakura A., Yoshimura M., Ohnishi Y., Itoh T. Detection and typing of lactate dehydrogenase-elevating virus RNA from transplantable tumors mouse liver tissues and cell lines using polymerase chain reaction. Lab. Anim. Sci. 1998;48:99–102. [PubMed] [Google Scholar]
  98. Grossmann A., Weiland E. Immunization with inactivated lactate dehydrogenase-elevating virus followed by virus infection favors the selection of hybridomas synthesizing antibodies cross-reacting with intermediate fila-ments and the LDV envelope protein VP3. Autoimmunity. 1991;8:329–333. doi: 10.3109/08916939109007641. [DOI] [PubMed] [Google Scholar]
  99. Grossmann A., Weiland F., Weiland E. Autoimmunity induced by lactate dehydrogenase-elevating virus: monoclonal autoantibodies against Golgi antigens and other subcellular elements. Autoimmunity. 1989;2:201–211. doi: 10.3109/08916938909014684. [DOI] [PubMed] [Google Scholar]
  100. Harty J.T., Chan S.P.K., Contag C.H., Plagemann P.G.W. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without inter-ference with virus replication. J. Neuroimmunol. 1987;15:195–206. doi: 10.1016/0165-5728(87)90093-2. [DOI] [PubMed] [Google Scholar]
  101. Harty J.T., Chan S.P., Plagemann P.G.W. Characteristics of monoclonal antibodies to the lactate dehydrogenase-elevating virus. Intervirology. 1987;27:53–60. doi: 10.1159/000149715. [DOI] [PubMed] [Google Scholar]
  102. Harty J.T., Plagemann P.G.W. Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not rec-ognized during natural infection. J. Virol. 1988;62:3210–3216. doi: 10.1128/jvi.62.9.3210-3216.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Harty J.T., Plagemann P.G.W. Monoclonal antibody protection from age-dependent poliomyelitis: implications regarding the pathogenesis of lactate dehydroge-nase-elevating virus. J. Virol. 1990;64:6257–6262. doi: 10.1128/jvi.64.12.6257-6262.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Haven T.R., Rowland R.R.R., Plagemann P.G.W., Wong G.H.W., Bradley S.E., Cafruny W.A. Regulation of transplacental virus infection by developmental and immunological factors: studies with lactate dehydrogenase-elevating virus. Virus Res. 1996;41:153–161. doi: 10.1016/0168-1702(96)01283-x. [DOI] [PubMed] [Google Scholar]
  105. Heremans H., Billiau A., Coutelier J.-P, De Somer P. The inhibition of endotoxin-induced local inflammation by LDH virus or LDH virus-infected tumors is mediated by interferon. Proc. Soc. Exp. Biol Med. 1987;185:6–15. doi: 10.3181/00379727-185-42509. [DOI] [PubMed] [Google Scholar]
  106. Horzinek M.C., Wielink P.S. Purification and electron microscopy of lactic dehydrogenase virus of mice. J. Gen. Virol. 1975;26:217–226. doi: 10.1099/0022-1317-26-3-217. [DOI] [PubMed] [Google Scholar]
  107. Hovinen D.E., Bradley D.S., Cafruny W.A. Analysis of immunoglobulin isotype blood levels splenic B-cell phenotypes and spleen cell immunoglobulin gene expression in mice infected with lactate dehydro-genase-elevating virus. Viral Immunol. 1990;3:27–40. doi: 10.1089/vim.1990.3.27. [DOI] [PubMed] [Google Scholar]
  108. Howard R.J., Notkins A.L., Mergenhagen S.E. Inhibition of cellular immune reactions in mice infected with lactic dehydrogenase virus. Nature. 1969;221:873–874. doi: 10.1038/221873a0. [DOI] [PubMed] [Google Scholar]
  109. Hu B., Even C., Plagemann P.G.W. Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: relationship to IgG2a-and IgG2b-specific polyclonal activation of B cells. Viral Immunol. 1992;5:27–38. doi: 10.1089/vim.1992.5.27. [DOI] [PubMed] [Google Scholar]
  110. Inada T. Replication of lactate dehydrogenase-elevating virus in various species cell lines infected with dual- ampho-and xenotropic murine leukaemia viruses in vitro. Virus Res. 1993;27:267–281. doi: 10.1016/0168-1702(93)90038-o. [DOI] [PubMed] [Google Scholar]
  111. Inada T., Kikuchi H., Yamazaki S. Comparison of the ability of lactate dehydrogenase-elevating virus and its virion RNA to infect murine leukemia virus-infected or-uninfected cell lines. J. Virol. 1993;67:5698–5703. doi: 10.1128/jvi.67.9.5698-5703.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Inada T., Mims C.A. Genetic basis for Ia positivity and suscepti-bility to lactic dehydrogenase virus in macrophages of SJL/J mice. Arch. Virol. 1987;92:77–85. doi: 10.1007/BF01310064. [DOI] [PubMed] [Google Scholar]
  113. Inada T., Kikuchi H., Yamazaki S. Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus. J. Gen. Virol. 1985;66:1469–1477. doi: 10.1099/0022-1317-66-7-1469. [DOI] [PubMed] [Google Scholar]
  114. Inada T., Kikuchi H., Yamazaki S. Infection of mice with lactic dehydrogenase virus prevents development of experimental allergic encephalomyelitis. J. Neuroimmunol. 1986;11:53–56. doi: 10.1016/0165-5728(86)90074-3. [DOI] [PubMed] [Google Scholar]
  115. Inada T., Kikuchi H., Yamazaki S. Live lactate dehydrogenase-elevating virus (LDV) induces suppressor T cells that inhibit the development of delayed hypersensitivity to LDV. J. Gen. Virol. 1986;67:2103–2112. doi: 10.1099/0022-1317-67-10-2103. [DOI] [PubMed] [Google Scholar]
  116. Inada T., Kikuchi H., Yamazaki S. Mouse Ia antigens are receptors for lactate dehydrogenase virus. Nature. 1984;309:59–61. doi: 10.1038/309059a0. [DOI] [PubMed] [Google Scholar]
  117. Inada T., Kikuchi H., Yamazaki S. Pattern of infection and selective loss of Ia positive cells in suckling and adult mice inoculated with lactic dehydrogenase virus. Arch. Virol. 1985;86:151–165. doi: 10.1007/BF01309821. [DOI] [PubMed] [Google Scholar]
  118. Inada T., Yamazaki S. Replication of lactate dehydrogenase-elevating virus in cells infected with murine leukaemia viruses in vitro. J. Gen. Virol. 1991;72:2437–2444. doi: 10.1099/0022-1317-72-10-2437. [DOI] [PubMed] [Google Scholar]
  119. Isakov N., Feldman M., Segal S. Acute infection of mice with lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of their macrophages. Cell. Immunol. 1982;66:317–332. doi: 10.1016/0008-8749(82)90182-4. [DOI] [PubMed] [Google Scholar]
  120. Isakov N., Feldman M., Segal S. Lactic dehydrogenase virus (LDV) impairs the antigen-presenting capacity of macrophages yet fails to affect their phagocytic activity. Immunobiology. 1982;162:15–27. doi: 10.1016/S0171-2985(11)80013-6. [DOI] [PubMed] [Google Scholar]
  121. Isakov N., Feldman M., Segal S. The mechanism of modulation of humoral immune responses after infection of mice with lactic dehydrogenase virus. J.Immunol. 1982;128:969–975. [PubMed] [Google Scholar]
  122. Isakov N., Segal S., Feldman M. The immunoregulatory charac-teristics of the lactic dehydrogenase virus (LDV) a common contaminant of tumors. Cell. Mol. Biol. Incl. Cyto. Enzymol. 1981;27:83–96. [PubMed] [Google Scholar]
  123. Kascsak R.J., Carp R.L, Donnenfeld H., Bartfeld H. Kinetics of replication of lactate dehydrogenase-elevating virus in age-dependent polioencephalomyelitis. Intervirology. 1983;19:6–15. doi: 10.1159/000149331. [DOI] [PubMed] [Google Scholar]
  124. Koi M., Saito M., Ebina T., Ishida N. Lactate dehydrogenase-elevating agent is responsible for interferon induction and enhancement of natural killer cell activity by inoculation of Ehrlich ascites carcinoma cells into mice. Microbiol. Immunol. 1981;25:565–574. doi: 10.1111/j.1348-0421.1981.tb00058.x. [DOI] [PubMed] [Google Scholar]
  125. Kowalchyk K., Plagemann P.G.W. Cell surface receptors for lac-tate dehydrogenase-elevating virus on subpopulation of macrophages. Virus Res. 1985;2:211–229. doi: 10.1016/0168-1702(85)90010-3. [DOI] [PubMed] [Google Scholar]
  126. Kuo L.L., Chen Z., Rowland R.R.R., Faaberg K.S., Plagemann P.G.W. Lactate dehydrogenase-elevating virus (LDV) : subgenomic mRNAs mRNA leader and comparison of 3'-terminal sequences of two LDV isolates. Virus Res. 1992;23:55–72. doi: 10.1016/0168-1702(92)90067-J. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Kuo L.L., Harty J.T., Erickson L., Palmer G.A., Plagemann P.G.W. A nested set of eight RNAs is formed in macrophages infected with lactate dehydrogenase-elevating virus. J. Virol. 1991;65:5118–5123. doi: 10.1128/jvi.65.9.5118-5123.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Lagwinska E., Stewart C.C., Adles C., Schlesinger S. Replication of lactic dehydrogenase virus and Sindbis virus in mouse peri-toneal macrophages. Induction of interferon and phenotypic mixing. Virology. 1975;65:204–214. doi: 10.1016/0042-6822(75)90021-5. [DOI] [PubMed] [Google Scholar]
  129. Leclercq G., Willems J., Heremans H., Coutelier J.P., Billiau A., Joniau M. Cellular immunity changes caused by LDH virus: analogy with observations on neuroblastoma-bearing mice. Int. J. Cancer. 1987;40:669–675. doi: 10.1002/ijc.2910400517. [DOI] [PubMed] [Google Scholar]
  130. Li K., Chen Z., Plagemann P.G.W. High-frequency homologous genetic recombination of an arterivirus lactate dehydrogenase-elevating virus in mice and evolution of neuropathogenic variants. Virology. 1999;258:73–83. doi: 10.1006/viro.1999.9660. [DOI] [PubMed] [Google Scholar]
  131. Leclercq G., Willems J., Heremans H., Coutelier J.P., Billiau A., Joniau M. The neutralization epitope of lactate dehydrogenase-elevat-ing virus is located on the short ectodomain of the primary envelope glycoprotein. Virology. 1998;242:239–245. doi: 10.1006/viro.1997.9014. [DOI] [PubMed] [Google Scholar]
  132. Li X., Hu B., Harty J., Even C., Plagemann P.G.W. Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase-elevating virus is partly dependent on CD4+ lympho-cytes. Viral Immunol. 1990;3:273–288. doi: 10.1089/vim.1990.3.273. [DOI] [PubMed] [Google Scholar]
  133. Li K., Schüler T., Chen Z., Glass G.E.G., Childs J.E., Plagemann P.G.W. Isolation of lactate dehydrogenase-elevating viruses from wild house mice and their biological and molecular characterization. Virus Res. 2000;67:153–162. doi: 10.1016/s0168-1702(00)00142-8. [DOI] [PubMed] [Google Scholar]
  134. Lussenhop N., Holmes B., Cafruny W.A., Plagemann P.G.W. Acute infection of mice with lactate dehydrogenase-elevating virus enhances Fc and complement receptor activity of peritoneal macrophages. J. Gen. Virol. 1982;61:25–32. doi: 10.1099/0022-1317-61-1-25. [DOI] [PubMed] [Google Scholar]
  135. Mahy B.W J. Action of Riley's plasma enzyme-elevating virus in mice. Virology. 1964;24:481–483. doi: 10.1016/0042-6822(64)90188-6. [DOI] [PubMed] [Google Scholar]
  136. Mahy B.W.J., Harvey J.J., Rowson K.E.K. Some physical properties of a murine sarcoma virus (Harvey) . Tex. Rep. Biol Med. 1966;24:620–628. [Google Scholar]
  137. Mahy B.W.J., Rowson K.E.K., Parr C.W. Studies on the mech-anism of action of Riley virus. IV. The reticuloendothelial system and impaired plasma enzyme clearance in infected mice. J Exp. Med. 1967;125:277–288. doi: 10.1084/jem.125.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Mahy B.W.J., Rowson K.E.K., Parr C.W., Salaman M.H. Studies on the mechanism of action of Riley virus. I. Action of substances affecting the reticuloendothelial system on plasma enzyme levels in mice. J Exp. Med. 1965;122:967–981. doi: 10.1084/jem.122.5.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Markine-Goriaynoff D., Coutelier J.P. Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants. J. Virol. 2002;76:432–435. doi: 10.1128/JVI.76.1.432-435.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Markine-Goriaynoff D., Hulhoven X., Cambiaso C.L. Natural killer cell activation after infection with lactate dehydrogenase-elevating virus. J. Gen. Virol. 2002;83:2709–2716. doi: 10.1099/0022-1317-83-11-2709. [DOI] [PubMed] [Google Scholar]
  141. Markine-Goriaynoff D., Nguyen T.D., Bigaignon G., Van Snick J., Coutelier J.P. Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms. Int. Immunol. 2001;13:1185–1192. doi: 10.1093/intimm/13.9.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Markine-Goriaynoff D., van der Logt J.T.M., Truyens C. IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. Int. Immunol. 2000;12:223–230. doi: 10.1093/intimm/12.2.223. [DOI] [PubMed] [Google Scholar]
  143. Martinez D. Histocompatibility-linked genetic control of susceptibility to age-dependent polioencephalomyelitis in mice. Infect. Immun. 1979;23:45–48. doi: 10.1128/iai.23.1.45-48.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Martinez D., Brinton M.A., Tachovsky T.G., Phelps A.H. Identification of lactate dehydrogenase-elevating virus as the etiologic agent of genetically restricted age-dependent polioencephalomyelitis of mice. Infect. Immun. 1980;27:979–987. doi: 10.1128/iai.27.3.979-987.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. McDonald T.L. Isolation of C1q-binding virus-antibody immune com-plexes from lactic dehydrogenase virus (LDV) -infected mice. Immunology. 1982;45:365–370. [PMC free article] [PubMed] [Google Scholar]
  146. Meite M., Léonard S., El Azami El Idrissi M., Izui S., Masson P.L., Coutelier J.P. Exacerbation of autoantibody-mediated hemolytic anemia by viral infection. J. Virol. 2000;74:6045–6049. doi: 10.1128/jvi.74.13.6045-6049.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Mergenhagen S.E., Notkins A.L., Dougherty S.F. Adjuvanticity of lactic dehydrogenase virus: influence of virus infection on the establishment of immunologic tolerance to a protein antigen in adult mice. J. Immunol. 1967;99:576–581. [PubMed] [Google Scholar]
  148. Meulenberg J.J., Hulst M.M., de Meijer E.J. Lelystad virus belongs to a new virus family comprising lactate dehydrogenase-elevating virus equine arteritis virus and simian hemorrhagic fever virus. Arch. Virol (Suppl.) . 1994;9:441–448. doi: 10.1007/978-3-7091-9326-6_43. [DOI] [PubMed] [Google Scholar]
  149. Meulenberg J.J., Hulst M.M., de Meijer E.J. Lelystad virus the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS) is related to LDV and EAV. Virology. 1993;192:62–72. doi: 10.1006/viro.1993.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Meulenberg J.J., Petersen-den Besten A., DeKluyver E.P., Moormann R.J., Schaaper W.M., Wensvoort G. Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus. Virology. 1995;206:155–163. doi: 10.1016/S0042-6822(95)80030-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Michaelides M.C., Schlesinger S. Effect of acute or chronic infection with lactic dehydrogenase virus (LDV) on the susceptibility of mice to plasmacytoma MOPC-315. J. Immunol. 1974;112:1560–1564. [PubMed] [Google Scholar]
  152. Michaelides M.C., Schlesinger S. Structural proteins of lactic dehydrogenase virus. Virology. 1973;55:211–217. doi: 10.1016/s0042-6822(73)81023-2. [DOI] [PubMed] [Google Scholar]
  153. Michaelides M.C., Simms E.S. Immune responses in mice infected with lactic dehydrogenase virus. I. Antibody response to DNP-BGG and hyperglobulinaemia in BALB/c mice. Immunology. 1977;32:981–988. [PMC free article] [PubMed] [Google Scholar]
  154. Michaelides M.C., Simms E.S. Immune responses in mice infected with lactic dehydrogenase virus. II. Contact sensitization to DNFB and characterization of lymphoid cells during acute LDV infection. Cell. Immunol. 1977;29:285–294. doi: 10.1016/0008-8749(77)90323-9. [DOI] [PubMed] [Google Scholar]
  155. Michaelides M.C., Simms E.S. Immune responses in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection. Cell Immunol. 1980;50:253–260. doi: 10.1016/0008-8749(80)90280-4. [DOI] [PubMed] [Google Scholar]
  156. Michaelides M.C., Simms E.S. Immune responses in mice infected with lactic dehydrogenase virus. IV. Functional status of the macrophage during acute LDV infection. Immunology. 1979;36:241–246. [PMC free article] [PubMed] [Google Scholar]
  157. Michelich V.J., Buoen L.C., Brand K.G. Immunosuppression studies in foreign body tumorigenesis: no evidence for tumor-specific anti-genicity. J. Natl. Cancer Inst. 1977;58:257–261. [PubMed] [Google Scholar]
  158. Monteyne P., Coulie P.G., Coutelier J.P. Analysis of the Fvl al-leles involved in the susceptibility of mice to lactate dehydrogenase-elevating virus-induced polioencephalomyelitis. J. Neurovirol. 2000;6:89–93. doi: 10.3109/13550280009006386. [DOI] [PubMed] [Google Scholar]
  159. Monteyne P., Coutelier J.P. Difference in neutralization between lactate dehydrogenase-elevating virus isolated from acutely and chronically infected mice. J. Gen. Virol. 1994;75:1173–1176. doi: 10.1099/0022-1317-75-5-1173. [DOI] [PubMed] [Google Scholar]
  160. Monteyne P., Meite M., Coutelier J.P. Involvement of CD4+ cells in the protection of C58 mouse against polioencephalomyelitis induced by lactate dehydrogenase-elevating virus. J. Neurovirol. 1997;3:380–384. doi: 10.3109/13550289709030752. [DOI] [PubMed] [Google Scholar]
  161. Monteyne P., Renauld J.-C., Van Broeck J., Dunne D.W., Brombacher F., Coutelier J.P. IL-4-independent regulation of in vivo IL-9 expression. J. Immunol. 1997;159:2616–2623. [PubMed] [Google Scholar]
  162. Monteyne P., Van Broeck J., Van Snick J., Coutelier J.P. Inhibition by lactate dehydrogenase-elevating virus of in vivo interleukin 4 production during immunization with keyhole limpet haemocyanin. Cytokine. 1993;5:394–397. doi: 10.1016/1043-4666(93)90073-e. [DOI] [PubMed] [Google Scholar]
  163. Morimoto M., Iwata H., Hayashi T. Lactic dehydrogenase virus inhibits allergic immunoglobulin E production: in vivo molecular analysis of cytokines. Scand. J. Immunol. 1999;50:211–214. doi: 10.1046/j.1365-3083.1999.00589.x. [DOI] [PubMed] [Google Scholar]
  164. Morimoto M., Yamamoto N., Hayashi T. Lactic dehydrogenase virus infection reduces the expulsion of the nematode Nippostrongylus brasiliensis. Parasitol Res. 2003;90:153–156. doi: 10.1007/s00436-001-0548-5. [DOI] [PubMed] [Google Scholar]
  165. Mundy J., Williams P.C. Transmissible agent associated with some mouse neoplasms. Science. 1961;134:834–835. doi: 10.1126/science.134.3482.834. [DOI] [PubMed] [Google Scholar]
  166. Murphy W.H., Nawrocki J.F., Pease L.R. Age-dependent para-lytic viral infection in C58 mice: possible implications in human neurologic disease. Prog. Brain Res. 1983;59:291–303. doi: 10.1016/S0079-6123(08)63874-1. [DOI] [PubMed] [Google Scholar]
  167. Murphy W.H., Tarn M.R., Lanzi R.L., Abell M.R., Kauffman C. Age dependence of immunologically induced central nervous system disease in C58 mice. Cancer Res. 1970;30:1612–1622. [PubMed] [Google Scholar]
  168. Musaji A., Cormont F., Thirion G., Cambiaso C.L., Coutelier J.P. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infec-tion with mouse viruses. Blood. 2004;104:2102–2106. doi: 10.1182/blood-2004-01-0310. [DOI] [PubMed] [Google Scholar]
  169. Nawrocki J.F., Pease L.R., Murphy W.H. Etiologic role of lactic dehydrogenase virus infection in an age-dependent neuroparalytic disease in C58 mice. Virology. 1980;103:259–264. doi: 10.1016/0042-6822(80)90147-6. [DOI] [PubMed] [Google Scholar]
  170. Niwa A., Yamazaki S., Bader J., Notkins A.L. Incorporation of labeled precursors into the RNA and proteins of lactic dehydrogenase virus. J. Virol. 1973;12:401–404. doi: 10.1128/jvi.12.2.401-404.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Notkins A.L. Enzymatic and immunologic alterations in mice infected with lactic dehydrogenase virus. Am. J Pathol. 1971;64:733–746. [PMC free article] [PubMed] [Google Scholar]
  172. Notkins A.L. Lactic dehydrogenase virus. Bacteriol. Rev. 1965;29:143–160. doi: 10.1128/br.29.2.143-160.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Notkins A.L. Studies of the properties and transmission of the lactic dehydrogenase agent. Proc. Am. Assoc. Cancer Res. 1963;4:48. [Google Scholar]
  174. Notkins A.L. Studies on the mechanism of enzyme elevation in mice infected with the lactic dehydrogenase virus. Fed. Proc Fed. Am. Soc. Exp. Biol. 1965;24:378. [Google Scholar]
  175. Notkins A.L., Berry R.J., Moloney J.B., Greenfield R.E. Relationship of the lactic dehydrogenase factor to certain murine tumours. Nature. 1962;193:79–80. doi: 10.1038/193079a0. [DOI] [PubMed] [Google Scholar]
  176. Notkins A.L., Mage M., Ashe W.K., Mahar S. Neutralization of sensitized lactic dehydrogenase virus by anti-gammaglobulin. J. Immunol. 1968;100:314–320. [PubMed] [Google Scholar]
  177. Notkins A.L., Mahar S., Scheele C., Goffman J. Infectious virus-antibody complex in the blood of chronically infected mice. J Exp. Med. 1966;124:81–97. doi: 10.1084/jem.124.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Notkins A.L., Mergenhagen S.E., Rizzo A.A., Scheele C., Waldmann T.A. Elevated γ-globulin and increased antibody production in mice infected with lactic dehydrogenase virus. J. Exp. Med. 1966;123:347–364. doi: 10.1084/jem.123.2.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Notkins A.L., Scheele C. Impaired clearance of enzymes in mice infected with the lactic dehydrogenase agent. J. Natl Cancer Inst. 1964;33:741–749. [PubMed] [Google Scholar]
  180. Notkins A.L., Scheele C. An infectious nucleic acid from the lactic dehydrogenase agent. Virology. 1963;20:640–642. doi: 10.1016/0042-6822(63)90291-5. [DOI] [PubMed] [Google Scholar]
  181. Notkins A.L., Shochat S.J. Studies on the multiplication and the properties of the lactic dehydrogenase agent. J Exp. Med. 1963;117:735–747. doi: 10.1084/jem.117.5.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Ochsenbein A.F., Fehr T., Lutz C. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 1999;286:2156–2159. doi: 10.1126/science.286.5447.2156. [DOI] [PubMed] [Google Scholar]
  183. Oldstone M.B.A., Dixon F.J. Inhibition of antibodies to nuclear antigen and to DNA in New Zealand mice infected with lactate dehydrogenase virus. Science. 1972;175:784–786. doi: 10.1126/science.175.4023.784. [DOI] [PubMed] [Google Scholar]
  184. Oldstone M.B.A., Tishon A., Chiller J.M. Chronic virus infection and immune responsiveness. II. Lactic dehydrogenase virus infection and immune response to non-viral antigens. J. Immunol. 1974;112:370–375. [PubMed] [Google Scholar]
  185. Onyekaba C.O., Harty J.T., Even C., Hu B.-G., Plagemann P.G W. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. Virus Res. 1989;14:297–315. doi: 10.1016/0168-1702(89)90023-3. [DOI] [PubMed] [Google Scholar]
  186. Onyekaba C.O., Harty J.T., Plagemann P.G.W. Extensive cyto-cidal replication of lactate dehydrogenase-elevating virus in cultured peritoneal macrophages from 1-2-week-old mice. Virus Res. 1989;14:327–338. doi: 10.1016/0168-1702(89)90025-7. [DOI] [PubMed] [Google Scholar]
  187. Palmer G.A., Kuo L., Chen Z., Faaberg K.S., Plagemann P.G.W. Sequence of the genome of lactate dehydrogenase-elevating virus: heterogenicity between strains P and C. Virology. 1995;209:637–642. doi: 10.1006/viro.1995.1296. [DOI] [PubMed] [Google Scholar]
  188. Pease L.R., Abrams G.D., Murphy W.H. FV-1 restriction of age-dependent paralytic lactic dehydrogenase virus infection. Virology. 1982;117:29–37. doi: 10.1016/0042-6822(82)90504-9. [DOI] [PubMed] [Google Scholar]
  189. Pease L.R., Murphy W.H. Co-infection by lactic dehydrogenase virus and C-type retrovirus elicits neurological disease. Nature. 1980;286:398–400. doi: 10.1038/286398a0. [DOI] [PubMed] [Google Scholar]
  190. Plagemann P.G.W. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus. Virology. 2001;290:11–20. doi: 10.1006/viro.2001.1139. [DOI] [PubMed] [Google Scholar]
  191. Plagemann P.G.W. An ORF-2a protein is not present at a significant level in viri-ons of the arterivirus lactate dehydrogenase-elevating virus. Virus Res. 2001;74:47–52. doi: 10.1016/S0168-1702(00)00247-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Plagemann P.G.W. Porcine reproductive and respiratory syndrome virus: origin hypothesis. Emerg. Infect. Dis. 2003;9:903–908. doi: 10.3201/eid0908.030232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Plagemann P.G.W., Chen Z., Li K. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution. Arch. Virol. 2001;146:1283–1296. doi: 10.1007/s007050170091. [DOI] [PubMed] [Google Scholar]
  194. Plagemann P.G.W., Gregory K.F., Swim H.E., Chan K.K.W. Plasma lactic dehydrogenase-elevating agent of mice: distribution in tissues and effect on lactic dehydrogenase isozyme patterns. Can. J. Microbiol. 1963;9:75–86. [Google Scholar]
  195. Plagemann P.G.W., Harty J.T., Even C. Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal anti-bodies. Arch. Virol. 1992;123:89–100. doi: 10.1007/BF01317140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Plagemann P.G.W., Jones Q.A., Cafruny W.A. N-glycans on the short ectodomain of the primary envelope glycoprotein play a major role in the polyclonal activation of B cells by lactate dehydrogenase-elevating virus. J. Gen. Virol. 2000;81:2167–2175. doi: 10.1099/0022-1317-81-9-2167. [DOI] [PubMed] [Google Scholar]
  197. Plagemann P.G.W., Moennig V. Lactate dehydrogenase-elevating virus equine arteritis virus and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv. Virus Res. 1992;41:99–192. doi: 10.1016/S0065-3527(08)60036-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Plagemann P.G.W., Rowland R.R.R., Even C., Faaberg K.S. Lactate dehydrogenase-elevating virus: an ideal persistent virus? Springer Semin. Immunopathol. 1995;17:167–186. doi: 10.1007/BF00196164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Plagemann P.G.W., Rowland R.R.R., Faaberg K.S. The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain. Arch. Virol. 2002;147:2327–2347. doi: 10.1007/s00705-002-0887-2. [DOI] [PubMed] [Google Scholar]
  200. Plagemann P.G.W., Swim H.E. Propagation of lactic dehydro-genase-elevating virus in cell culture. Proc. Soc. Exp. Biol Med. 1966;121:1147–1152. doi: 10.3181/00379727-121-30991. [DOI] [PubMed] [Google Scholar]
  201. Plagemann P.G.W., Swim H.E. Relationship between the lactic dehydrogenase-elevating virus and transplantable murine tumors. Proc. Soc. Exp. Biol Med. 1966;121:1142–1146. doi: 10.3181/00379727-121-30990. [DOI] [PubMed] [Google Scholar]
  202. Plagemann P.G.W., Swim H.E. Studies of the plasma lactic dehydrogenase-elevating virus (PLDEV) of mice. Proc. Am. Assoc. Cancer Res. 1963;4:53. [Google Scholar]
  203. Pope J.H. Studies of a virus isolated from a wild house mouse Mus musculus and producing splenomegaly and lymph node enlargement in mice. Aust. J Exp. Biol Med. Sci. 1961;39:521–536. doi: 10.1038/icb.1961.53. [DOI] [PubMed] [Google Scholar]
  204. Pope J.H., Rowe W.P. Identification of WM1 as LDH virus and its recovery from wild mice in Maryland. Proc. Soc. Exp. Biol Med. 1964;116:1015–1019. doi: 10.3181/00379727-116-29436. [DOI] [PubMed] [Google Scholar]
  205. Porter D.D., Porter H.G. Deposition of immune complexes in the kidneys of mice infected with lactic dehydrogenase virus. J. Immunol. 1971;106:1264–1266. [PubMed] [Google Scholar]
  206. Porter D.D., Porter H.G., Deerhake B.B. Immunofluorescence assay for antigen and antibody in lactic dehydrogenase virus infection of mice. J. Immunol. 1969;102:431–436. [PubMed] [Google Scholar]
  207. Proffitt M.R., Congdon C.C. The effect of a large dose of LDH virus on mouse lymphatic tissue. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1970;29:559. [Google Scholar]
  208. Riley V. Lactate dehydrogenase in the normal and malignant state in mice and the influence of a benign enzyme-elevating virus. Methods Cancer Res. 1968;4:493–618. [Google Scholar]
  209. Riley V. Persistence and other characteristics of the lactate dehydro-genase elevating virus (LDH-virus) . Prog. Med. Virol. 1974;18:198–213. [PubMed] [Google Scholar]
  210. Riley V. Role of viruses in glycolysis of tumors and hosts. Fed. Proc Fed. Am. Soc. Exp. Biol. 1962;21:21–87. [Google Scholar]
  211. Riley V. Virus-tumor synergism. Science. 1961;134:666–668. doi: 10.1126/science.134.3480.666-a. [DOI] [PubMed] [Google Scholar]
  212. Riley V., Lilly F., Huerto E., Bardell D. Transmissible agent asso-ciated with 26 types of experimental mouse neoplasms. Science. 1960;132:545–547. doi: 10.1126/science.132.3426.545. [DOI] [PubMed] [Google Scholar]
  213. Riley V., Loveless J.D., Fitzmaurice M.A., Siler W.M. Mechanism of lactate dehydrogenase (LDH) elevation in virus-infected hosts. Life Sci. 1965;4:487–507. doi: 10.1016/0024-3205(65)90098-6. [DOI] [PubMed] [Google Scholar]
  214. Riley V., Wroblewski F. Serial lactic dehydrogenase activity in plasma of mice with growing or regressing tumors. Science. 1960;132:151–152. doi: 10.1126/science.132.3420.151. [DOI] [PubMed] [Google Scholar]
  215. Ritzi D.M., Holth M., Smith M.S. Replication of lactate dehy-drogenase-elevating virus in macrophages. 1. Evidence for cytocidal replication. J. Gen. Virol. 1982;59:245–262. doi: 10.1099/0022-1317-59-2-245. [DOI] [PubMed] [Google Scholar]
  216. Rowland R.R.R., Butz E.A., Plagemann P.G.W. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus. J. Immunol. 1994;152:5785–5795. [PubMed] [Google Scholar]
  217. Rowland R.R.R., Even C., Anderson G.W., Chen Z., Hu B., Plagemann P.G.W. Neonatal infection of mice with lactate dehydrogenase-elevat-ing virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation. J. Gen. Virol. 1994;75:1071–1081. doi: 10.1099/0022-1317-75-5-1071. [DOI] [PubMed] [Google Scholar]
  218. Rowson K.E.K. Riley virus in wild mice effect of drugs on repli-cation of Riley viruses. Br. Emp. Cancer Campaign Annu. Rep. 1963;41:222–223. [Google Scholar]
  219. Rowson K.E.K., Adams D.H., Salaman M.H. Riley's enzymes elevating virus: a study of the infection in mice and its relation to virus-induced leukaemia. Acta. Unio Int. Contra Cancrum. 1963;19:404–406. [PubMed] [Google Scholar]
  220. Rowson K.E.K., Mahy B.W.J. Lactic dehydrogenase virus. Virol. Monogr. 1975;13:1–121. doi: 10.1007/978-3-7091-8378-6_1. [DOI] [PubMed] [Google Scholar]
  221. Rowson K.E.K., Mahy B.W.J., Bendinelli M. Riley virus neutralizing activity in the plasma of infected mice with persistent viraemia. Virology. 1966;28:775–778. doi: 10.1016/0042-6822(66)90268-6. [DOI] [PubMed] [Google Scholar]
  222. Rowson K.E.K., Michaels L. Lactic dehydrogenase (LDH) virus and its localization by immunofluorescence. J. Med. Microbiol. 1973;6:xi. [PubMed] [Google Scholar]
  223. Rowson K.E.K., Parr I.B., Alper T. Radiation target size of Riley virus. Virology. 1968;36:157–159. [PubMed] [Google Scholar]
  224. Santisteran G.A., Riley V., Fitzmaurice M.A. Thymolytic and adrenal cortical responses to the LDH-elevating virus. Proc Soc Exp. Biol. Med. 1972;139:202–206. doi: 10.3181/00379727-139-36109. [DOI] [PubMed] [Google Scholar]
  225. Schlenker E.H., Jones Q.A., Rowland R.R.R., Steffen-Bien M., Cafruny W.A. Age-dependent poliomyelitis in mice is associated with respiratory failure and viral replication in the central nervous system and lung. J. Neurovirol. 2001;7:265–271. doi: 10.1080/13550280152403308. [DOI] [PubMed] [Google Scholar]
  226. Sillevis Smitt P.A.E., de Jong J.M.B.M. Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies. J. Neurol. Sci. 1989;91:231–258. doi: 10.1016/0022-510x(89)90056-7. [DOI] [PubMed] [Google Scholar]
  227. Smit M.J., Duursma A.M., Koudstaal J., Hardonk M.J., Bouma J.M. Infection of mice with lactate dehydrogenase-elevating virus destroys the subpopulation of Kupffer cells involved in receptor-mediated endocytosis of lactate dehydrogenase and other enzymes. Hepatology. 1990;12:1192–1199. doi: 10.1002/hep.1840120519. [DOI] [PubMed] [Google Scholar]
  228. Snijder E.J., Brinton M.A., Faaberg K.S. Arteriviridae. In: V. Regenmortal M.H., Fauquet C.M., L. Bishop D.H., editors. Virus taxonomy eighth report of the international committee on taxonomy of viruses. Springer-Verlag Wien; New York: 2003. [Google Scholar]
  229. Snodgrass M.J., Lowrey D.S., Hanna M.G., Jr. Changes induced by lactic dehydrogenase virus in thymus and thymus-dependent areas of lymphatic tissue. J. Immunol. 1972;108:877–892. [PubMed] [Google Scholar]
  230. Stevenson M.M., Rees J.C., Meltzer M.S. Macrophage function in tumor-bearing mice: evidence for lactic dehydrogenase-elevating virus-associated changes. J. Immunol. 1980;124:2892–2899. [PubMed] [Google Scholar]
  231. Stewart C.C., Lin H.S., Adles C. Proliferation and colony-forming ability of peritoneal exudate cells in liquid culture. J Exp. Med. 1975;141:1114–1132. doi: 10.1084/jem.141.5.1114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  232. Stroop W.G., Brinton M.A. Enhancement of encephalomyelo-radiculitis in mice sensitized with spinal cord tissue and infected with lactate dehydrogenase-elevating virus. J. Neuroimmunol. 1985;8:79–92. doi: 10.1016/S0165-5728(85)80049-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Stroop W.G., Brinton M.A. Mouse strain-specific central nervous system lesions associ-ated with lactate dehydrogenase-elevating virus infection. Lab. Invest. 1983;49:334–345. [PubMed] [Google Scholar]
  234. Stroop W.G., Weibel J., Schaefer D., Brinton M.A. Ultrastructural and immunofluorescent studies of acute and chronic lactate dehydrogenase elevating virus-induced nonparalytic poliomyelitis in mice. Proc. Soc. Exp. Biol. Med. 1985;178:261–274. doi: 10.3181/00379727-178-42009. [DOI] [PubMed] [Google Scholar]
  235. Stueckemann J.A., Holth M., Swart W.J. Replication of lactate dehydrogenase-elevating virus in macrophages. 2. Mechanism of persistent infection in mice and cell culture. J. Gen. Virol. 1982;59:263–272. doi: 10.1099/0022-1317-59-2-263. [DOI] [PubMed] [Google Scholar]
  236. Stueckemann J., Plagemann P.G.W. ICN-UCLA symposia on molecular and cellular biology. Academic Press; New York: 1978. Persistent infection of mouse peritoneal exudate cells by lactate dehydrogenase-elevating virus (LDV) in vitro; p. 247. [Google Scholar]
  237. Takei L, Asaba Y., Kasatani T. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J. Autoimmun. 1992;5:665–673. doi: 10.1016/0896-8411(92)90184-r. [DOI] [PubMed] [Google Scholar]
  238. Tennant R.W., Ward T.G. Pneumonia virus of mice (PVM) in cell culture. Proc. Soc. Exp. Biol. Med. 1962;111:395–398. doi: 10.3181/00379727-111-27803. [DOI] [PubMed] [Google Scholar]
  239. Tong S.L., Stueckemann J., Plagemann P.G.W. Autoradiographic method for detection of lactate dehydrogenase-elevating virus-infected cells in primary mouse macrophage cultures. J. Virol. 1977;22:219–227. doi: 10.1128/jvi.22.1.219-227.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. van den Broek M.F., Sporri R., Even C. Lactate dehydrogenase-elevating virus (LDV) : lifelong coexistence of virus and LDV-specific immunity. J. Immunol. 1997;159:1585–1588. [PubMed] [Google Scholar]
  241. van der Logt J.T.M., Kissing J., Melchers W.J. Enzymatic amplification of lactate dehydrogenase-elevating virus. J. Clin. Microbiol. 1994;32:2003–2006. doi: 10.1128/jcm.32.8.2003-2006.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. Verdonck E., Pfau C.J., Gonzalez M.-D., Masson P.L., Coutelier J.-P. Influence of viral infection on anti-erythrocyte autoantibody response after immunization of mice with rat red blood cells. Autoimmunity. 1994;17:73–81. doi: 10.3109/08916939409014660. [DOI] [PubMed] [Google Scholar]
  243. Virolainen M., Defendi V. Dependence of macrophage growth in vitro upon interaction with other cells. In: Defendi V., Stoker M., editors. Growth regulating substances for animal cells in culture. Wistar Inst. Press; Philadelphia: 1967. pp. 67–83. [PubMed] [Google Scholar]
  244. Warnock M.L. Isozymic patterns in organs of mice infected with LDH agent. Proc. Soc. Exp. Biol. Med. 1964;115:448–452. doi: 10.3181/00379727-115-28938. [DOI] [PubMed] [Google Scholar]
  245. Weiland E., Grossmann A., Thiel H.J., Weiland F. Lactate dehy-drogenase-elevating virus induces antibodies reactive with a surface antigen of aetiologically unrelated murine cell transformants. J. Gen. Virol. 1990;71:1233–1236. doi: 10.1099/0022-1317-71-5-1233. [DOI] [PubMed] [Google Scholar]
  246. Weiland E., Weiland F., Grossmann A. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies. J. Gen. Virol. 1987;68:1983–1991. doi: 10.1099/0022-1317-68-7-1983. [DOI] [PubMed] [Google Scholar]
  247. Yaffe D. The distribution and in vitro propagation of an agent causing high plasma lactic dehydrogenase activity. Cancer Res. 1962;22:573–580. [PubMed] [Google Scholar]
  248. Yamazaki S., Notkins A.L. Inhibition of replication of lactic dehydrogenase virus by actinomycin. J. Virol. 1973;11:473–478. doi: 10.1128/jvi.11.4.473-478.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Mouse in Biomedical Research are provided here courtesy of Elsevier

RESOURCES